John R. Bennett CV

PUBLICATIONS AND PRESENTATIONS:

Ear Anomalies, ENT Update for Pediatricians, November 2017

Rhinosinusitis, ENT Update for General Practitioners, November 2016

ENT Infections, ENT Update for General Practitioners, November 2014

Pediatric Ear Disease, Utah Chapter National Association of Pediatric Nurse Practitioners, September 2014

Review of ENT Care, Lecture to Primary Care, Hill AFB Clinic, Utah, 2007

Rhinoplasty Techniques, Grand Rounds lecture to residents of Tripler Army Medical Center, Honolulu, Hawaii – February 2005

Tip Rhinoplasty Techniques, Grand Rounds Lecture to University of Utah Otolaryngology Department, Salt Lake City, Utah – 2004

Quantitative Measurements of Rhytidectomy, Stanford University Otolaryngology Annual Meeting, June 2004

Reconstruction and Repair of Facial Lesions, Grand Rounds lecture to residents of Tripler Army Medical Center, Honolulu, Hawaii – November 2002

Facial Anatomy cadaver demonstration to residents and medical students, Stanford University Medical Center, Palo Alto, California, May 2003

Rhinoplasty Techniques and Case Review, Grand Rounds lecture to residents and medical students of Stanford University Medical Center, Palo Alto, California – October 2002

Suture Techniques and Soft Tissue Repair, lecture and laboratory supervision of residents and medical students of Stanford University Medical Center, Palo Alto, California – September 2002

Schall DG, Bennett JR, Chapter 16: Aeromedical Evacuation of Otorhinolaryngology Head and Neck Surgery Patients. J Medical Aspects of Aeromedical Evacuation, Springer-Verlag – 1999

Medical Management of the Traumatized Patient, Grand Rounds lecture to residents of the University of Texas at San Antonio and the San Antonio Uniformed Services Health Education Consortium – January 1999

Rhinoplasty, Grand Rounds lecture to residents of the University of Texas at San Antonio and the San AntonioUniformed Services Health Education Consortium – August 1998

Bennett JR, Syms CA, Arriaga MA, Dahlen RT, Preoperative Evaluation of Brain Hernia within the Temporal Bone. Poster presentation to American Academy of Otolaryngology – Head and Neck Surgery, San Francisco, California – September 1997
– Presentation to San Antonio Society of Otolaryngology, – May 1998

Bennett JR, Morehead JM, Yu LM, Holck DE, Roberts SE, Sphenoid Sinus Lymphoma Presenting with Acute Unilateral Opthalmoplegia. Poster presentation to American Society of Pediatric Otolaryngology, Scottsdale, Arizona – May 1997

Bennett JR, Ow RA, Clark WD, Retropharyngeal Abscess Complicating Adenoidectomy Performed with an Electrocautery Adenoid Curette. Poster presentation to American Academy of Otolaryngology – Head and Neck Surgery, Washington, DC – September 1996

Bennett JR, The effect of Turbinectomy on the Olfactory Nerve – An Anatomical Study. Presentation to British Association of Clinical Anatomists, Sheffield, United Kingdom, – June 1994
– Also presented to Society of Air Force Clinical Surgeons, San Antonio, Texas – April 1994, winning “Surgeon General’s Award”

PAST AND ONGOING RESEARCH:

Multiple industrial research projects including:

Effect of XXX in Severe Bilateral Nasal Polyps (SYNAPSE). 2017. Sponsored by GlaxoSmithKline Research.

Efficacy and Safety of XXX as Acute Sudden Sensorineural Hearing Loss Treatment (ASSENT). 2017. Sponsored by Auris Medical.

A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of XXX Given As A Single Administration For Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Patients. 2016. Sponsored by Otonomy.

A 6-Month, Multicenter, Phase 3, Open-Label Extension Safety Study of XXX Given At 3-Month Intervals By Intratympanic Injection In Subjects With Unilateral Meniere’s Disease. 2016. Sponsored by Otonomy.

XXX in the Post-Acute Treatment of Peripheral Tinnitus 1 (AMPACT1)- an open-label extension to the TACTT2 study. 2015. Sponsored by Auris Medical.

A Prospective Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase 3 Study Efficacy and Safety of XXX Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere’s Disease. 2015. Sponsored by Otonomy.

Safety and Efficacy of XXX Sinus Implant Following Surgical Opening of the Frontal Sinus For Chronic Sinusitis. 2015. Sponsored by Intersect ENT.

A Clinical Evaluation of the Safety and Efficacy of the XXX Sinus Implant in Chronic Sinusitis Patients with Recurrent Sinus Obstruction. 2015. Sponsored by Intersect ENT.

An 8-Week, Prospective Multicenter, Open-Label Study of XXX Given As A Single Administration In Pediatric Subjects With A History of Otitis Media Requiring Tympanostomy Tube Placement. 2015. Sponsored by Otonomy.

Safety and Efficacy of XXX Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion. 2015. Sponsored by Alcon Research.

Efficacy and Safety of XXX in the Treatment of Acute Peripheral Tinnitis 2 (TACTT2). 2014. Sponsored by Auris.

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2b Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease. 2013. Sponsored by Otonomy.

A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO-201 Given As a Single Intratympanic Injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring Tympanostomy Tube Placement. 2013. Sponsored by Otonomy.

Proof-of-Concept of Single Application of XXX Otic Suspension in Treatment of Acute Otitis media with Tympanostomy Tubes Compared to CIPRODEX (BID for 7 days). 2013. Sponsored by Alcon.

A 16-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety. 2013. Sponsored by Optinose.

A 12-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administion of µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A 3-Month Open-Label Multicenter Study Evaluating the Safety of Intranasal Administration of 400 µg of XXX Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects with Chronic Sinusitis With or Without Nasal Polyps. 2013. Sponsored by Optinose.

A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing XXX Sinus Implant Used in Post-Sinus Surgery Patients with Recurrent Sinus Obstruction. 2013. Sponsored by Intersect ENT.

A Clinical Evaluation of the Mechanical Contribution of XXX Sinus Implant in Improving Sinus Patency and Symptoms When Used in Post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction-Ethmoid Sinus Patency (ESP) Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of the Steroid-Eluting S8 Sinus Implant Used Following Endoscopic Sinus Surgery (ESS) in Patients with Chronic Sinusitis-XXX Surgical Pilot Study. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX in Improving Sinus Patency and Symptoms When Used in Post-Sinus Surgery Patients with Recurrent Ethmoid Sinus Obstruction. 2012. Sponsored by Intersect ENT.

A Clinical Evaluation of XXX Used Following Endoscopic Sinus Surgery in Patients with Chronic Sinusitis. 2012. Sponsored by Intersect ENT.

A Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of XXX plus XXX compared to XXX and to XXX in the Treatment of Acute Otitis Media with Tympanostomy Tubes (AOMT) in Pediatric Patients. 2012. Sponsored by Laboratorios SALVAT, S.A.

Safety and Efficacy Evaluation of Topical XXX Otic Suspension in the Treatment of Acute Otitis Externa. 2012. Sponsored by Alcon Research, Ltd.

A Clinical Evaluation of the XXX Used in Post-Sinus Surgery Patients with Recurrent Sinus Obstruction. 2011. Sponsored by Intersect ENT.

Topical Treatment of Acute Otitis Media through Tympan ostomy Tubes (AOMT) and its Effect on Microbial Flora Distal to the Site of Infection. 2011. Alcon Research, Ltd.

Safety and Efficacy Evaluation of Topical XXX in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. 2010. Sponsored by Alcon Research Ltd.

Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. 2010. Sponsored by Alcon Research Ltd.

A Clinical Evaluation of XXX when Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic Sinusitis. 2009. Sponsored by Intersect ENT.

Safety of XXX in Patients with Perennial Allergic Rhinitis. 2009. Alcon Research, Ltd.

A Clinical Evaluation of XXX When Used Following Functional Endoscopic Sinus Surgery in Patients with Chronic Sinusitis. 2009. Sponsored by Sinexus Inc.

A Clinical Evaluation of XXX When Used Following Functional Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis. 2008. Sponsored by Sinexus Inc.

Safety and Efficacy of XXX in the Treatment of Acute Otitis Externa. 2008. Sponsored by Alcon Research Ltd.

Safety and Efficacy of XXX in the Treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes. 2006. Sponsored by Alcon Research Ltd.

Phase II Trial Comparing Doses and Duration of XXX in Subjects with Acute Maxillary Sinusitis Diagnosed by Antral TAP. 2005 Sponsored by Replidyne.

XXX vs. XXX Trial to assess the safety and efficacy of XXX in the treatment of subjects with acute diffuse otitis externa in children, adolescents, and adults. 2004 Laboratorios SALVAT, S.A. through PAREXEL.

An Open uncontrolled trial to evaluate the time to bacterial eradication and key symptom relief in the treatment of Acute Bacterial Maxillary Sinusitis with XXX QD. 2004 Sponsored by Bayer Corporation.